Modafinil 100 Ipharma. 100 mg Tablets
PDF Leaflet Revision Date: 16 November 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Improves wakefulness in patients with excessive daytime sleepiness associated with narcolepsy.
Dosage (summary)
200 mg/day as a single morning dose; consider lower doses in elderly and hepatic impairment.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding due to potential risks.
Key Drug Interactions
- Anticonvulsants
- Steroidal contraceptives
- Antidepressants
- Anticoagulants
Contraindications
- Hypersensitivity to modafinil
- Major anxiety
- Children under 16
- Severe renal impairment
- Uncontrolled hypertension
- Cardiac dysrhythmias
Common side effects
- Headache
- Dizziness
- Nausea
- Insomnia
- Anxiety
Counselling Points
- Maintain good sleep hygiene
- Monitor for psychiatric symptoms
- Use alternative contraception methods
- Avoid driving if affected by sleepiness
Serious warnings
- Serious rash (SJS, TEN)
- Psychiatric disorders
- Cardiovascular risks
- Multi-organ hypersensitivity
Important Disclaimer
The Modafinil 100 Ipharma. 100 mg Tablets professional information leaflet below is the property of Ipharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
